Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-012691
Filing Date
2016-09-27
Accepted
2016-09-27 09:54:46
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q stlt_10q.htm 10-Q 327886
2 CERTIFICATION stlt_ex311.htm EX-31.1 8787
3 CERTIFICATION stlt_ex312.htm EX-31.2 8785
4 CERTIFICATION stlt_ex321.htm EX-32.1 3742
  Complete submission text file 0001477932-16-012691.txt   2086247

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT stlt-20160331.xml EX-101.INS 343910
6 XBRL TAXONOMY EXTENSION SCHEMA stlt-20160331.xsd EX-101.SCH 29929
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stlt-20160331_cal.xml EX-101.CAL 36985
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stlt-20160331_def.xml EX-101.DEF 86462
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stlt-20160331_lab.xml EX-101.LAB 168840
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stlt-20160331_pre.xml EX-101.PRE 142178
Mailing Address 6750 WESTOWN PARKWAY SUITE 200-226 WEST DES MOINES IA 50266
Business Address 6750 WESTOWN PARKWAY SUITE 200-226 WEST DES MOINES IA 50266 515-274-9087
Spotlight Innovation, Inc. (Filer) CIK: 0001388486 (see all company filings)

EIN.: 980518266 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52542 | Film No.: 161903478
SIC: 2834 Pharmaceutical Preparations